- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.67 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 5 residues within 4Å:- Chain A: D.189, E.193
- Ligands: MG.3, EN4.4, 81B.5
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.189, A:E.193, H2O.3, H2O.8
MG.3: 4 residues within 4Å:- Chain A: D.189
- Ligands: MG.2, EN4.4, 81B.5
5 PLIP interactions:1 interactions with chain A, 4 Ligand-Water interactions- Metal complexes: A:D.189, H2O.1, H2O.4, H2O.19, H2O.20
MG.9: 4 residues within 4Å:- Chain B: D.189
- Ligands: EN4.6, 81B.7, MG.10
5 PLIP interactions:1 interactions with chain B, 4 Ligand-Water interactions- Metal complexes: B:D.189, H2O.2, H2O.17, H2O.17, H2O.20
MG.10: 5 residues within 4Å:- Chain B: D.189, E.193
- Ligands: EN4.6, 81B.7, MG.9
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.189, B:E.193, H2O.19, H2O.24
- 2 x EN4: [cyclopentyl(hydroxy)amino](oxo)acetic acid(Non-covalent)
EN4.4: 13 residues within 4Å:- Chain A: G.130, P.131, D.189, E.193, C.198
- Chain B: E.229, I.249, S.250, A.253
- Ligands: NDP.1, MG.2, MG.3, 81B.5
9 PLIP interactions:5 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:P.131, B:I.249
- Hydrogen bonds: A:D.189, A:E.193, B:S.250, B:A.253
- Water bridges: A:K.129, A:K.129, B:S.250
EN4.6: 14 residues within 4Å:- Chain A: E.229, I.233, I.249, S.250, A.253
- Chain B: G.130, P.131, D.189, E.193, C.198
- Ligands: 81B.7, NDP.8, MG.9, MG.10
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:I.233, A:I.249, B:P.131
- Hydrogen bonds: A:S.250, B:D.189
- Water bridges: A:S.250
- 2 x 81B: (cyclopentylamino)(oxo)acetic acid(Non-covalent)
81B.5: 14 residues within 4Å:- Chain A: G.130, P.131, D.189, E.193, C.198
- Chain B: E.229, I.233, I.249, S.250, A.253
- Ligands: NDP.1, MG.2, MG.3, EN4.4
8 PLIP interactions:5 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:I.233, B:I.249, A:P.131
- Hydrogen bonds: B:E.229, B:S.250, A:E.193
- Water bridges: B:S.250, A:K.129
81B.7: 14 residues within 4Å:- Chain A: E.229, I.233, I.249, S.250, A.253
- Chain B: G.130, P.131, D.189, E.193, C.198
- Ligands: EN4.6, NDP.8, MG.9, MG.10
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:I.233, A:I.249, B:P.131
- Hydrogen bonds: A:E.229, A:S.250
- Water bridges: A:S.250
- 1 x IMD: IMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kandale, A. et al., Design, synthesis, in vitro activity and crystallisation of novel N-isopropyl-N-hydroxyoxamate derivatives as ketol-acid reductosiomerase (KARI) inhibitor. To Be Published
- Release Date
- 2019-01-30
- Peptides
- Ketol-acid reductoisomerase (NADP(+)): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.67 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x EN4: [cyclopentyl(hydroxy)amino](oxo)acetic acid(Non-covalent)
- 2 x 81B: (cyclopentylamino)(oxo)acetic acid(Non-covalent)
- 1 x IMD: IMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kandale, A. et al., Design, synthesis, in vitro activity and crystallisation of novel N-isopropyl-N-hydroxyoxamate derivatives as ketol-acid reductosiomerase (KARI) inhibitor. To Be Published
- Release Date
- 2019-01-30
- Peptides
- Ketol-acid reductoisomerase (NADP(+)): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B